Di Nardo, Lucia
 Distribuzione geografica
Continente #
AS - Asia 1.024
NA - Nord America 997
EU - Europa 547
SA - Sud America 204
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.808
Nazione #
US - Stati Uniti d'America 957
SG - Singapore 478
CN - Cina 231
BR - Brasile 168
VN - Vietnam 102
DE - Germania 93
FR - Francia 92
SE - Svezia 88
IT - Italia 80
GB - Regno Unito 42
JP - Giappone 42
IN - India 39
FI - Finlandia 34
IE - Irlanda 34
ID - Indonesia 31
HK - Hong Kong 26
CA - Canada 22
RU - Federazione Russa 22
BD - Bangladesh 21
PL - Polonia 17
KR - Corea 14
ZA - Sudafrica 12
MX - Messico 10
AR - Argentina 8
CI - Costa d'Avorio 8
ES - Italia 8
BE - Belgio 6
EC - Ecuador 6
IQ - Iraq 6
NL - Olanda 6
PK - Pakistan 6
TR - Turchia 6
BO - Bolivia 5
KE - Kenya 5
UA - Ucraina 5
CO - Colombia 4
JO - Giordania 4
LT - Lituania 4
PE - Perù 4
AT - Austria 3
CL - Cile 3
MA - Marocco 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CR - Costa Rica 2
CY - Cipro 2
MD - Moldavia 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 2.808
Città #
Singapore 248
Chandler 132
San Jose 120
Ashburn 100
Beijing 46
Hefei 46
The Dalles 41
Tokyo 39
Dallas 34
Dublin 34
Lauterbourg 34
Ho Chi Minh City 33
New York 31
Hanoi 27
Jakarta 27
Rome 25
Los Angeles 24
Frankfurt am Main 23
Helsinki 23
Hong Kong 23
Milan 19
Boston 17
Bremen 17
Kent 17
Munich 17
Council Bluffs 16
Moscow 15
Santa Clara 14
Seoul 14
São Paulo 14
Warsaw 14
Chicago 13
St Louis 13
Princeton 12
London 11
Atlanta 10
Hyderabad 10
Redwood City 10
Düsseldorf 9
North Bergen 9
Nuremberg 9
San Mateo 9
Abidjan 8
Wilmington 8
Chennai 7
Stockholm 7
Brussels 6
Lappeenranta 6
Montreal 6
Orem 6
Ottawa 6
Boardman 5
Johannesburg 5
Mexico City 5
Paris 5
Pune 5
Rio de Janeiro 5
Toronto 5
Turku 5
Amman 4
Amsterdam 4
Boydton 4
Brooklyn 4
Buffalo 4
Cleveland 4
Da Nang 4
Denver 4
Falkenstein 4
Haiphong 4
Nairobi 4
Portsmouth 4
Roubaix 4
Ankara 3
Araraquara 3
Baghdad 3
Bologna 3
Campinas 3
Can Tho 3
Dhaka 3
Guarulhos 3
Guayaquil 3
Hillsboro 3
Houston 3
Lima 3
Manchester 3
Marseille 3
Mumbai 3
Nova Iguaçu 3
Poplar 3
Porto Alegre 3
Ribeirão das Neves 3
Salvador 3
Southampton 3
Taubaté 3
Ajax 2
Baku 2
Bauru 2
Belo Horizonte 2
Betim 2
Bexley 2
Totale 1.629
Nome #
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 133
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 122
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 114
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies 110
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 108
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 98
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 96
Histological features of immune cell infiltrate in lesional skin correlate with therapeutic response to dupilumab 93
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 93
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors 93
Understanding the molecular genetics of basal cell carcinoma 93
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis 92
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study 91
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 91
Familial Melanoma: Diagnostic and Management Implications 89
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 88
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 88
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 87
Molecular alterations in basal cell carcinoma subtypes 87
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 82
Intra-patient heterogeneity of BRAF and NRAS molecular alterations in primary melanoma and metastases 81
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab 79
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies 77
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study 77
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 73
Melanoma types by in vivo reflectance confocal microscopy correlated with protein and molecular genetic alterations: A pilot study 73
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 72
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series 66
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 65
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 61
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review 59
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 53
CGRP increase in tear fluid of migraine patients is reversed by anti-CGRP monoclonal antibodies 32
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review 31
Totale 2.847
Categoria #
all - tutte 12.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 2 0
2021/202283 1 1 1 6 7 1 1 10 3 7 21 24
2022/2023338 36 44 26 62 28 36 11 32 39 6 11 7
2023/2024261 7 46 27 34 16 28 9 8 9 6 36 35
2024/2025630 10 2 43 12 58 30 24 18 71 74 156 132
2025/20261.492 228 70 127 207 218 91 273 85 92 101 0 0
Totale 2.847